Predicting Survivability of Cancer Patients with Metastatic Patterns Using Explainable AI

• URL: http://arxiv.org/abs/2504.06306v1
• Date: Mon, 07 Apr 2025 20:48:15 GMT
• Title: Predicting Survivability of Cancer Patients with Metastatic Patterns Using Explainable AI
• Authors: Polycarp Nalela, Deepthi Rao, Praveen Rao,
• Abstract summary: This study leverages machine learning (ML) to predict the survivability of cancer patients with metastatic patterns.<n>MSK-MET dataset includes genomic and clinical data from 25,775 patients across 27 cancer types.<n>XGBoost emerged as the best performer with an area under the curve (AUC) of 0.82.
• Score: 2.6182192515316247
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Cancer remains a leading global health challenge and a major cause of mortality. This study leverages machine learning (ML) to predict the survivability of cancer patients with metastatic patterns using the comprehensive MSK-MET dataset, which includes genomic and clinical data from 25,775 patients across 27 cancer types. We evaluated five ML models-XGBoost, Na\"ive Bayes, Decision Tree, Logistic Regression, and Random Fores using hyperparameter tuning and grid search. XGBoost emerged as the best performer with an area under the curve (AUC) of 0.82. To enhance model interpretability, SHapley Additive exPlanations (SHAP) were applied, revealing key predictors such as metastatic site count, tumor mutation burden, fraction of genome altered, and organ-specific metastases. Further survival analysis using Kaplan-Meier curves, Cox Proportional Hazards models, and XGBoost Survival Analysis identified significant predictors of patient outcomes, offering actionable insights for clinicians. These findings could aid in personalized prognosis and treatment planning, ultimately improving patient care.

Related papers

• MIL vs. Aggregation: Evaluating Patient-Level Survival Prediction Strategies Using Graph-Based Learning [52.231128973251124]
  We compare various strategies for predicting survival at the WSI and patient level. The former treats each WSI as an independent sample, mimicking the strategy adopted in other works. The latter comprises methods to either aggregate the predictions of the several WSIs or automatically identify the most relevant slide.
  arXiv  Detail & Related papers  (2025-03-29T11:14:02Z)
• Prediction of Lung Metastasis from Hepatocellular Carcinoma using the SEER Database [0.9055332067000195]
  Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality.<n> predictive models for lung metastasis inHCC remain limited in scope and clinical applicability.<n>We develop and validate an end-to-end machine learning pipeline using data from the Surveillance, Epidemiology, and End Results (SEER) database.
  arXiv  Detail & Related papers  (2025-01-20T20:06:31Z)
• Machine Learning for ALSFRS-R Score Prediction: Making Sense of the Sensor Data [44.99833362998488]
  Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease that presents individuals with limited treatment options. The present investigation, spearheaded by the iDPP@CLEF 2024 challenge, focuses on utilizing sensor-derived data obtained through an app.
  arXiv  Detail & Related papers  (2024-07-10T19:17:23Z)
• Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging [71.91773485443125]
  Grading plays a vital role in breast cancer treatment planning. The current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. This paper examines using optimized CDI$s$ to improve breast cancer grade prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:48:26Z)
• Survival Prediction Across Diverse Cancer Types Using Neural Networks [40.392772795903795]
  Gastric cancer and Colon adenocarcinoma represent widespread and challenging malignancies. Medical community has embraced the 5-year survival rate as a vital metric for estimating patient outcomes. This study introduces a pioneering approach to enhance survival prediction models for gastric and Colon adenocarcinoma patients.
  arXiv  Detail & Related papers  (2024-04-11T21:47:13Z)
• Semi-supervised ViT knowledge distillation network with style transfer normalization for colorectal liver metastases survival prediction [1.283897253352624]
  We propose an end-to-end approach for automated prognosis prediction using histology slides stained with H&E and HPS. We first employ a Generative Adversarial Network (GAN) for slide normalization to reduce staining variations and improve the overall quality of the images that are used as input to our prediction pipeline. We exploit the extracted features for the metastatic nodules and surrounding tissue to train a prognosis model. In parallel, we train a vision Transformer (ViT) in a knowledge distillation framework to replicate and enhance the performance of the prognosis prediction.
  arXiv  Detail & Related papers  (2023-11-17T03:32:11Z)
• Pathology-and-genomics Multimodal Transformer for Survival Outcome Prediction [43.1748594898772]
  We propose a multimodal transformer (PathOmics) integrating pathology and genomics insights into colon-related cancer survival prediction. We emphasize the unsupervised pretraining to capture the intrinsic interaction between tissue microenvironments in gigapixel whole slide images. We evaluate our approach on both TCGA colon and rectum cancer cohorts, showing that the proposed approach is competitive and outperforms state-of-the-art studies.
  arXiv  Detail & Related papers  (2023-07-22T00:59:26Z)
• Penalized Deep Partially Linear Cox Models with Application to CT Scans of Lung Cancer Patients [42.09584755334577]
  Lung cancer is a leading cause of cancer mortality globally, highlighting the importance of understanding its mortality risks to design effective therapies. The National Lung Screening Trial (NLST) employed computed tomography texture analysis to quantify the mortality risks of lung cancer patients. We propose a novel Penalized Deep Partially Linear Cox Model (Penalized DPLC), which incorporates the SCAD penalty to select important texture features and employs a deep neural network to estimate the nonparametric component of the model.
  arXiv  Detail & Related papers  (2023-03-09T15:38:16Z)
• Recurrence-free Survival Prediction under the Guidance of Automatic Gross Tumor Volume Segmentation for Head and Neck Cancers [8.598790229614071]
  We developed an automated primary tumor (GTVp) and lymph nodes (GTVn) segmentation method. We extracted radiomics features from the segmented tumor volume and constructed a multi-modality tumor recurrence-free survival (RFS) prediction model.
  arXiv  Detail & Related papers  (2022-09-22T18:44:57Z)
• Deep learning-based approach to reveal tumor mutational burden status from whole slide images across multiple cancer types [41.61294299606317]
  Tumor mutational burden (TMB) is a potential genomic biomarker of immunotherapy. TMB detected through whole exome sequencing lacks clinical penetration in low-resource settings. In this study, we proposed a multi-scale deep learning framework to address the detection of TMB status from routinely used whole slide images.
  arXiv  Detail & Related papers  (2022-04-07T07:02:32Z)
• Lymph Node Graph Neural Networks for Cancer Metastasis Prediction [0.342658286826597]
  We present a novel graph-based approach to incorporate imaging characteristics of existing cancer spread to local lymph nodes. We trained an edge-gated Graph Convolutional Network (Gated-GCN) to accurately predict the risk of distant metastasis.
  arXiv  Detail & Related papers  (2021-06-03T09:28:14Z)
• Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
  Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM) We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients. xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
  arXiv  Detail & Related papers  (2021-02-10T15:10:37Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.